| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/12/2005 | EP1228043B1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 01/12/2005 | CN1564821A 5-methoxy-8-aryl-[1, 2, 4]triazolo[1, 5-a]pyridine derivatives as adenosine receptor antagonists |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564686A 8-amino- [1, 2, 4]triazolo [1, 5-a]pyridine-6-carboxylic acid amide |
| 01/12/2005 | CN1563005A Ramification in albocarbon category and application in anoxia system |
| 01/12/2005 | CN1563004A Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 01/12/2005 | CN1183989C Reaction crystallizing method for improving grain size |
| 01/11/2005 | US6841679 Acylation of 2-(phenyl)-imidazo(1,2-a)pyridine derivative with oxalyl halide derivative to form anxiolytic agent; reduction, salt formation |
| 01/11/2005 | US6841678 Hofmann degradation of amide to amine |
| 01/11/2005 | US6841671 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841558 Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors |
| 01/11/2005 | US6841556 Treatment of diseases such as rheumatoid arthritis (in connection with inflammation), osteoarthritis or asthma |
| 01/11/2005 | US6841555 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 01/11/2005 | US6841552 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders |
| 01/11/2005 | US6841549 Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2100924C Oxadiazine derivatives |
| 01/06/2005 | WO2005000849A1 5ht2c receptor agonists for the treatment of diabetes and obesity |
| 01/06/2005 | WO2005000848A1 Pyrido` 2, 1-a - isoquinoline derivatives as dpp-iv inhibitors |
| 01/06/2005 | WO2005000847A1 White-emitting compounds, process for the production thereof, and white-emitting devices |
| 01/06/2005 | WO2005000846A1 Hexahydropyridoisoqinolines as dpp-iv inhibitors |
| 01/06/2005 | WO2005000845A2 Bicyclic derivatives as nk-1 and nk-2 antagonists |
| 01/06/2005 | WO2005000828A1 Quinone based compound, photosensitive article for electrophotography and electrophotographic device using the same |
| 01/06/2005 | WO2005000806A2 Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| 01/06/2005 | WO2005000304A1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 01/06/2005 | WO2005000303A1 Pyrazolo`3,4-b!pyridin-6-ones as gsk-3 inhibitors |
| 01/06/2005 | WO2004101573A9 Synthesis of substituted heterocyclic compounds |
| 01/06/2005 | US20050004364 Diagnosis, therapy anxiety; Down' s Syndrome; sleep disorders; cognition activators; anticonvulsants |
| 01/06/2005 | US20050004363 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004200 Pyrazole compounds as integrin receptor antagonists derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004189 Thiazole compounds as integrin receptor antagonists derivatives |
| 01/06/2005 | US20050004162 Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use |
| 01/06/2005 | US20050004160 Reducing expression of highly proliferate genes; antibacterial and/or antiviral activity; cancer, tumors |
| 01/06/2005 | US20050004159 for example, 8-(1-ethylpropyl)-3-mesityl-2,5-dimethyl-8H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine; having an excellent corticotrophin-releasing-factor receptor antagonistic activity |
| 01/06/2005 | US20050004156 Kinesin inhibitors |
| 01/06/2005 | US20050004154 1,2,8-Triazaspiro{decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 01/06/2005 | US20050004147 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 01/06/2005 | US20050004144 Broad spectrum, long lasting, nontoxic synthetic immunostimulatory agents; inducing interferon production; inosine monophosphate dehydrogenase (IMPDH); cancer, autoimmune diseases |
| 01/06/2005 | US20050004141 Coupling piperidine oxime derivative to pyrido[1,2-a]pyrimidin-4-one component and cyclizing; yield, low cost, purity |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004129 Pyrazole derivatives |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004122 Such as 1(R)-{2,2-Dimethyl-3(R)-[1-(3,4-dichlorophenyl)-3-pyridin-3-yl-1H-pyrazol-5-yl ]cyclobutyl}acetic acid; farnesyl-protein transferase and geranylgeranyl-protein transferase inhibitors |
| 01/06/2005 | US20050004117 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 01/06/2005 | US20050004113 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050003286 Naphthalenetetracarboxylic acid diimide derivatives and electrophotographic photoconductive material having the same |
| 01/06/2005 | US20050001202 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 01/06/2005 | CA2529083A1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors |
| 01/05/2005 | EP1493744A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493742A1 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 01/05/2005 | EP1492790A1 Imidazo fused compounds |
| 01/05/2005 | EP1492787A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492568A1 Cancer treatment method comprising administration of an erb-family inhibitor and a raf and/or ras inhibitor |
| 01/05/2005 | EP1492533A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis |
| 01/05/2005 | EP0996619B1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/05/2005 | DE10327439A1 Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel New Imidazopyridazinon- and Imidazopyridonderivate, their preparation and their use as medicaments |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1560055A Tetrahydropyridoethers |
| 01/05/2005 | CN1560054A Compound of pyrazole [4, 3-c] quinolines and preparation process thereof |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183131C Process for aqueous preparation of small size linear quinacridone |
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/05/2005 | CN1183115C 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 01/05/2005 | CN1183111C Cycloalkano-indole and cycloalkane-azaindole derivatives, process for their preparation and pharmaceutical commposition containing the same |
| 01/05/2005 | CN1182782C Synergistic herbicidal composition and method for preventing and control of weeds |
| 01/05/2005 | CN1182781C Synergistic herbicidal composition and method for preventing and control of weeds |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838457 Fused heteroaryl derivatives |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838453 Therapy for osteoporosis |
| 01/04/2005 | CA2340999C 5-arylindole derivatives |
| 12/30/2004 | US20040267014 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 12/30/2004 | US20040267010 For therapy of central nervous system disorders |
| 12/30/2004 | US20040266842 Thiazolyl substituted triazoles as alk5 inhibitors |
| 12/30/2004 | US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis |
| 12/30/2004 | US20040266816 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders |
| 12/30/2004 | US20040266815 Alzheimer's disease, bipolar disorder, diabetes, dementia, stroke, schizophrenia, depression, hair loss, cancer |
| 12/30/2004 | US20040266814 Imidazopyridine compounds having 5-HT4 receptor agonistic activity and 5-HT3 receptor antagonistic activity |
| 12/30/2004 | US20040266812 (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione |
| 12/30/2004 | US20040266804 Camptothecin analogs having an E-ring ketone |
| 12/30/2004 | US20040266799 Corticotropin-releasing factor (CRF); such as 4-chloro-2-methyl-5-nitro-8-(2,4-dichloro)phenyl-1,7-naphthyridine for treating stroke, anxiety, depression, and/or irritable bowel syndrome |
| 12/30/2004 | US20040266796 Convergent processes for the synthesis of a GARFT inhibitor containing a methyl substituted thiophene core and intermediates therefor |
| 12/30/2004 | US20040266791 risperidone dihydrochloride, risperidone hydrogenmaleate, risperidone hemitartrate and risperidone hemimalate |
| 12/30/2004 | US20040266790 formed by contacting a risperidone donor suchas risperidone acetate with a chloride ion donor such as HCl in a solvent; serotonin antagonist approved for the treatment of psychotic disorders such as schizophrenia |
| 12/30/2004 | US20040266788 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatase |
| 12/30/2004 | US20040266778 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |